Onconic Therapeutics Unveils Pancreatic Cancer Trial Data at ASCO, Patient Survives Over 40 Months FirstWord Pharma
‘Game changer’ experimental drug doubles survival time for pancreatic cancer, trial shows CBC
‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long The Washington Post
Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease The Conversation
Promising new treatment for pancreatic cancer doubles survival rates PBS